β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceBalance Sheet
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Cash And Cash Equivalents | Short Term Investments | Cash And Short Term Investments | Net Receivables | Inventory | Other Current Assets | Total Current Assets | Property Plant Equipment Net | Goodwill | Intangible Assets | Goodwill And Intangible Assets | Long Term Investments | Tax Assets | Other Non Current Assets | Total Non Current Assets | Other Assets | Total Assets | Account Payables | Short Term Debt | Tax Payables | Deferred Revenue | Other Current Liabilities | Total Current Liabilities | Long Term Debt | Deferred Revenue Non Current | Deferred Tax Liabilities Non Current | Other Non Current Liabilities | Total Non Current Liabilities | Other Liabilities | Capital Lease Obligations | Total Liabilities | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Income Loss | Other Total Stockholders Equity | Total Stockholders Equity | Total Equity | Total Liabilities And Stockholders Equity | Minority Interest | Total Liabilities And Total Equity | Total Investments | Total Debt | Net Debt |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 484.6 | 0.0 | 484.6 | 552.5 | 377.0 | 124.0 | 1538.1 | 1686.1 | 106.1 | 10.8 | 116.9 | 202.1 | 26.0 | 74.3 | 2105.4 | -0.1 | 3643.4 | 239.3 | 17.89 | 50.3 | 49.6 | 193.3 | 550.4 | 284.39 | 0.0 | 20.5 | 105.8 | 410.7 | 0.0 | 99.7 | 961.1 | 0.0 | 18.8 | 3956.6 | -258.1 | -1035.0 | 2682.3 | 2682.3 | 3643.4 | 0.0 | 3643.4 | 202.1 | 302.3 | -182.3 |
2023-12 | 853.9 | 0.0 | 853.9 | 512.0 | 434.7 | 135.8 | 1936.4 | 1512.5 | 108.5 | 15.1 | 123.6 | 210.0 | 25.7 | 21.3 | 1893.1 | 0.0 | 3829.5 | 242.4 | 151.69 | 31.0 | 41.7 | 205.0 | 671.8 | 157.3 | 0.0 | 12.7 | 106.7 | 276.7 | 0.0 | 102.2 | 948.5 | 0.0 | 18.8 | 3523.4 | -143.8 | -517.4 | 2881.0 | 2881.0 | 3829.5 | 0.0 | 3829.5 | 210.0 | 309.0 | -544.9 |
2022-12 | 894.3 | 0.0 | 894.3 | 507.4 | 414.8 | 103.0 | 1919.5 | 1262.7 | 107.3 | 18.39 | 125.7 | 204.9 | 65.59 | 38.4 | 1697.3 | 0.0 | 3616.8 | 215.4 | 34.2 | 38.5 | 57.3 | 173.6 | 519.0 | 299.7 | 2.1 | 14.3 | 98.9 | 412.9 | 0.0 | 109.0 | 931.9 | 0.0 | 18.8 | 2987.8 | -183.0 | -138.69 | 2684.9 | 2684.9 | 3616.8 | 0.0 | 3616.8 | 204.9 | 317.89 | -576.4 |
2021-12 | 762.6 | 0.0 | 762.6 | 489.0 | 378.4 | 112.0 | 1742.0 | 1126.8 | 109.9 | 23.0 | 132.9 | 207.7 | 48.5 | 55.9 | 1571.8 | 0.0 | 3313.8 | 232.2 | 62.8 | 39.29 | 48.7 | 211.1 | 594.1 | 271.8 | 69.4 | 4.9 | 107.6 | 384.3 | 0.0 | 72.3 | 978.4 | 0.0 | 18.8 | 2456.69 | -159.6 | 19.5 | 2335.4 | 2335.4 | 3313.8 | 0.0 | 3313.8 | 207.7 | 325.3 | -437.3 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more balance sheet data for West Pharmaceutical Services!
Sign up for free or log inπ Claim your free eBook: "The Checklist Value Investor β A Smarter Way to Pick Stocks"